Job Title: Equity Research Associate, Biotechnology

Location: New York, NY

Firm Overview:
Cantor Fitzgerald, with over 16,000 employees, has been a leading global financial services firm at the forefront of financial and technological innovation since 1945.

Cantor is a preeminent investment bank serving more than 5,000 institutional clients around the world, recognized for its strengths in fixed income and equity capital markets, investment banking, SPAC underwriting, PIPE placements, commercial real estate, and for its global distribution platform. Capitalizing on the firm’s financial acumen and technology prowess, Cantor’s portfolio of businesses also includes Prime Brokerage, Asset Management, and other businesses and ventures. Cantor has consistently fueled the growth of original ideas, pioneered new markets, and provided superior service to clients. Cantor operates trading desks in every major financial center globally, with offices in over 30 locations around the world.

As one of the few remaining private partnerships on Wall Street, Cantor has the distinct ability to focus on long-term value creation and solid relationship building. Our structure allows us to respond quickly to client needs, develop solutions that address complex challenges, avoid the limitations of bureaucracy, and attract talented individuals who are driven to succeed.

Responsibilities:
Cantor Fitzgerald is seeking an Equity Research Associate to join its biotechnology research team. The ideal candidate is a highly motivated individual who will work directly with Senior Research Analysts and contribute to industry-leading research efforts. The role offers significant exposure to company management teams, industry conferences, and institutional clients, along with opportunities for increased responsibility and career development.

• Analyze individual biotechnology companies and market trends, producing company-specific and thematic research reports
• Build and maintain detailed financial models
• Interview physicians and Key Opinion Leaders across various disease areas
• Conduct deep scientific and clinical due diligence
• Perform scientific literature reviews
• Collaborate with Cantor’s institutional sales force, traders, and investment clients

Educational Qualifications:

• Exceptional academic pedigree, including a graduate degree in life sciences (Ph.D. and/or M.D. strongly preferred)
• Clear demonstration of outstanding academic achievement
• Coursework or demonstrated interest in economics, business, or finance preferred

Additional Qualifications:

• Outstanding analytical skills with the ability to research, analyze, and draw conclusions from complex information
• Excellent verbal and written communication skills
• Proven ability and desire to work collaboratively in a team environment
• Strong work ethic and high level of integrity
• Attention to detail, intellectual curiosity, and a strong interest in the biotechnology industry

Salary: $100,000 - $175,000
The actual base salary will be determined on an individualized basis considering a wide range of factors including, but not limited to, relevant skills, experience, education, and, where applicable, licenses or certifications held. In addition to base salary and a competitive benefits package (including health, vision, and dental insurance, paid time off and a 401(k) retirement), this position may be eligible for additional types of compensation including discretionary bonuses and other short- and long-term incentives (e.g., deferred cash, equity, etc.).

We do not accept unsolicited resumes, candidate referrals, or outreach from third-party recruiters or staffing agencies. Any such submissions will be considered property of Cantor Fitzgerald and will not be eligible for any placement fee. Recruiters must have a signed agreement with our Talent Acquisition team and be invited to submit candidates for a specific role. Direct contact with hiring managers or employees is strictly prohibited.